FISH: ALK-1 BREAKAPART REARRANGEMENT

A PHP Error was encountered

Severity: 8192

Message: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated

Filename: models/Product_model.php

Line Number: 247

Backtrace:

File: /home/lilj9s9ph51h/public_html/truemedix/models/Product_model.php
Line: 247
Function: json_decode

File: /home/lilj9s9ph51h/public_html/truemedix/controllers/Pages.php
Line: 138
Function: get_related

File: /home/lilj9s9ph51h/public_html/index.php
Line: 316
Function: require_once

FISH: ALK-1 BREAKAPART REARRANGEMENT

191 Ratings

Rs 11,570 Rs 8,900

23 % OFF

ANAPLASTIC LYMPHOMA KINASE (ALK) ENCODES A RECEPTOR TYROSINE KINASE & ALK GENE REARRANGEMENT (ALK+) IS IMPLICATED IN THE ONCOGENESIS OF NON-SMALL CELL LUNG CARCINOMAS (NSCLC) SPECIALLY ADENOCARCINOMAS. PATIENTS WITH SUCH TUMORS HAVE BEEN SHOWN TO RESPOND TO THE ALK KINASE INHIBITOR CRIZOTINIB (XALKORI). PATIENTS WITH ALK+ ANAPLASTIC LARGE CELL LYMPHOMAS ALSO SHOW GOOD RESPONSE ON TREATMENT WITH CRIZOTINIB.

Get a Free Call

To Know about Services Detail or any Enquiry.

A PHP Error was encountered